Pfizer banks on King Pharma’s new painkillers

Published October 17, 2010

Pfizer banks on King Pharma’s new painkillers
Pfizer’s purchase of King Pharmaceuticals announced Tuesday represents a $ 3.6 billion investment in an emerging class of painkillers that are designed to be less addictive than older pills such as OxyContin. The new products have been touted by federal health officials as an important way to curb prescription drug abuse, but they are relatively untested in the marketplace.
Read more on AP via Yahoo! News

Love can ease pain, say brain researchers
Love hurts, at least according to many a romantic songwriter, but it may also help ease pain, US scientists suggest. Brain scans suggest many of the areas normally involved in pain response are also activated by amorous thoughts.
Read more on BBC Radio 1 Newsbeat